(R)-α-[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]phenylacetic acid | 87276-01-5

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (R)-α-[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]phenylacetic acid
• 英文别名: 2-(4-ethyl-2,3-dioxopiperazinocarbonylamino)-2-phenylacetic acid；D-2-[(4-Ethyl-2,3-dioxopiperazin-1-yl)carbonylamino]-2-phenylacetic acid；α-[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]benzeneacetic acid；(D)-2-(4-ethyl-2,3-dioxopiperazine-1-carbonylamino)-2-phenylacetic acid；(-)-α-(4-ethyl-2,3-dioxo-1-piperazinylcarbonylamino)phenylacetic acid；R,2-[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonylamino]-2-phenylacetic acid；α-(4-ethyl-2,3-dioxo-1-piperazinecarbonyl)aminophenylacetic acid；D-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-2-phenylacetic acid；[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]phenylacetic acid；D(-)-α-(4-ethyl-2,3-dioxo-1-piperazinylcarbonylamino)phenylacetic acid；D(-)-alpha-(4-ethyl-2,3-dioxo-1-piperazinyl-carbonylamino)-phenylacetic acid；D-α-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)phenylacetic acid；(4-Ethyl-2,3-dioxopiperazine-1-carbonylamino)(phenyl)acetic acid；2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetic acid
• CAS: 87276-01-5
• 化学式: C₁₅H₁₇N₃O₅
• 分子量: 319.317
• InChiKey: JQEHQELQPPKXRR-UHFFFAOYSA-N

物化性质

• 密度：
  1.377±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  23
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  107
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  (R)-α-[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]phenylacetic acid 在 palladium on activated charcoal 吡啶 、 氢气 、 1-羟基苯并三唑 、 二异丙胺 、 N,N'-二环己基碳二亚胺 作用下， 以 乙醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 6.5h， 生成 <2S-<2α,3β(R*)>>-3-<((((4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)phenylacetyl)amino>-2-methyl-4-oxo-1-azetidinyl sulfate, pyridine salt
  参考文献：
  名称：

  O-Sulfated .beta.-lactam hydroxamic acids (monosulfactams). Novel monocyclic .beta.-lactam antibiotics of synthetic origin

  摘要：

  DOI：

  10.1021/ja00386a035

文献信息

• [EN] PENICILLIN-BINDING PROTEIN INHIBITORS<br/>[FR] INHIBITEURS DE PROTÉINE DE LIAISON À LA PÉNICILLINE
  申请人：VENATORX PHARMACEUTICALS INC

  公开号：WO2021108023A1

  公开（公告）日：2021-06-03

  Described herein are certain boron-containing compounds, compositions, preparations and their use as modulators of the transpeptidase function of bacterial penicillin-binding proteins and as antibacterial agents. In some embodiments, the compounds described herein inhibit penicillin-binding proteins. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.

  本文描述了某些含硼化合物、组合物、制剂及其作为细菌青霉素结合蛋白的跨肽酶功能调节剂和抗菌剂的用途。在某些实施例中，本文描述的化合物抑制青霉素结合蛋白。在某些实施例中，本文描述的化合物在治疗细菌感染方面是有用的。
• 1-Sulfo-2-oxoazetidine derivatives and their production
  申请人：Takeda Chemical Industries, Ltd.

  公开号：US04550105A1

  公开（公告）日：1985-10-29

  Disclosed are compounds of the general formula: ##STR1## wherein R.sub.1 is amino, an acylated amino or a protected amino group, X is hydrogen or methoxy, and R' is hydrogen, R or R.sup.4 wherein R is an organic residue attached to the azetidine ring through a carbon atom therein and R.sub.4 is azido, a halogen, an amino group which may optionally be acylated or a group of the formula --OR.sub.5, ##STR2## or --S--S--R.sub.5 wherein R.sub.5 is an organic residue and n is 0, 1 or 2, and pharmaceutically acceptable salts and esters thereof. The compounds have antimicrobial and/or .beta.-lactamase-inhibitory activity and are of value as drugs for human beings and domesticated animals.

  揭示了一般式为：其中R₁为氨基、酰化氨基或保护氨基，X为氢或甲氧基，R'为氢、R或R⁴，其中R为有机残基，通过其中的碳原子连接到氮杂环上，R⁴为叠氮基、卤素、氨基（可选地酰化）或具有如下结构的基团--OR₅，或--S--S--R₅，其中R₅为有机残基，n为0、1或2，以及其药学上可接受的盐和酯。这些化合物具有抗微生物和/或β-内酰胺酶抑制活性，并且作为人类和驯养动物的药物具有价值。
• 1-sulfo-2-oxoazetidine derivatives and their production
  申请人：Takeda Chemical Industries, Ltd.

  公开号：US04782147A1

  公开（公告）日：1988-11-01

  Disclosed are compounds of the general formula: ##STR1## wherein R.sub.1 is amino, an acylated amino or a protected amino group, X is hydrogen or methoxy, and R' is hydrogen, R or R.sup.4 wherein R is an organic residue attached to the azetidine ring through a carbon atom therein and R.sub.4 is azido, a halogen, an amino group which may optionally be acylated or a group of the formula ##STR2## wherein R.sub.5 is an organic residue and n is 0, 1 or 2, and pharmaceutically acceptable salts and esters thereof. The compounds have antimicrobial and/or .beta.-lactamase-inhibitory activity and are of value as drugs for human beings and domesticated animals.

  揭示了一般式化合物：##STR1## 其中 R.sub.1 是氨基、酰化氨基或保护氨基，X 是氢或甲氧基，而 R' 是氢、R 或 R.sup.4，其中 R 是通过其中的一个碳原子连接到环的有机残基，而 R.sub.4 是偶氮基、卤素、氨基（可选地酰化）或式 ##STR2## 其中 R.sub.5 是有机残基，n 为 0、1 或 2，以及其药学上可接受的盐和酯。这些化合物具有抗微生物和/或β-内酰胺酶抑制活性，并且作为人类和驯化动物的药物具有价值。
• [EN] PRODRUG INHIBITORS<br/>[FR] INHIBITEURS DE PROMÉDICAMENT
  申请人：UNIV LEIDEN

  公开号：WO2020204715A1

  公开（公告）日：2020-10-08

  Provided herein are compounds useful as metallo-β-lactamase (MBL) inhibitors. The compounds have a formula A–B, where A is a β-lactam antibiotic moiety comprising a bridging methylene (-CH2-) covalently attached to -B; and B is a latent MBL inhibitor. Also provided are formulations comprising such compounds; as well as such compounds or formulations for use as a medicament. The compounds and formulations may be used in the treatment of antibiotic resistance, bacterial infection. The compounds and formulations may be used in the inhibition of a bacterial MBL.

  本文提供了作为金属β-内酰胺酶（MBL）抑制剂有用的化合物。这些化合物具有A-B的结构式，其中A是一种β-内酰胺类抗生素基团，包括与-B共价连接的桥联甲基（-CH2-）；而B是一种潜在的MBL抑制剂。还提供了包含这些化合物的配方；以及这些化合物或配方用作药物的用途。这些化合物和配方可用于治疗抗生素耐药性、细菌感染。这些化合物和配方可用于抑制细菌MBL。
• .beta.-Lactam antibacterial agents
  申请人：Beecham Group p.l.c.

  公开号：US04539149A1

  公开（公告）日：1985-09-03

  .beta.-Lactam antibiotics having an .alpha.-formamido substituent on the carbon atom adjacent to the carbonyl group of the .beta.-lactam ring and in particular bicyclic compounds having the partial structure: ##STR1## Intermediates and processes for the preparation of the compounds are further disclosed.

  具有β-内酰胺环上与羰基相邻的碳原子上的α-甲酰氨基取代基的β-内酰胺类抗生素，特别是具有部分结构的双环化合物：##STR1## 进一步揭示了制备这些化合物的中间体和过程。